Rhizochalinin Exhibits Anticancer Activity and Synergizes with EGFR Inhibitors in Glioblastoma In Vitro Models.
Dyshlovoy SA, Hauschild J, Venz S, Krisp C, Kolbe K, Zapf S, Heinemann S, Fita KD, Shubina LK, Makarieva TN, Guzii AG, Rohlfing T, Kaune M, Busenbender T, Mair T, Moritz M, Poverennaya EV, Schlüter H, Serdyuk V, Stonik VA, Dierlamm J, Bokemeyer C, Mohme M, Westphal M, Lamszus K, von Amsberg G, Maire CL.
Dyshlovoy SA, et al. Among authors: von amsberg g.
Mol Pharm. 2023 Oct 2;20(10):4994-5005. doi: 10.1021/acs.molpharmaceut.3c00217. Epub 2023 Sep 21.
Mol Pharm. 2023.
PMID: 37733943